{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:31:26Z","timestamp":1793878286709,"version":"4.7.0"},"reference-count":58,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81XWH-07-2-067"],"award-info":[{"award-number":["W81XWH-07-2-067"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1DP1DA034787-01"],"award-info":[{"award-number":["1DP1DA034787-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>An improved synthesis of a haptenic heroin surrogate 1 (6-AmHap) is reported. The intermediate needed for the preparation of 1 was described in the route in the synthesis of 2 (DiAmHap). A scalable procedure was developed to install the C-3 amido group. Using the Boc protectng group in 18 allowed preparation of 1 in an overall yield of 53% from 4 and eliminated the necessity of preparing the diamide 13. Hapten 1 was conjugated to tetanus toxoid and mixed with liposomes containing monophosphoryl lipid A as an adjuvant. The 1 vaccine induced high anti-1 IgG levels that reduced heroin-induced antinociception and locomotive behavioral changes following repeated subcutaneous and intravenous heroin challenges in mice and rats. Vaccinated mice had reduced heroin-induced hyperlocomotion following a 50 mg\/kg heroin challenge. The 1 vaccine-induced antibodies bound to heroin and other abused opioids, including hydrocodone, oxycodone, hydromorphone, oxymorphone, and codeine.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.7b01427","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T14:49:21Z","timestamp":1513176561000},"page":"329-343","source":"Crossref","is-referenced-by-count":64,"title":["A Stable Heroin\nAnalogue That Can Serve as a Vaccine\nHapten to Induce Antibodies That Block the Effects of Heroin and Its\nMetabolites in Rodents and That Cross-React Immunologically with Related\nDrugs of Abuse"],"prefix":"10.1021","volume":"61","author":[{"given":"Agnieszka","family":"Sulima","sequence":"first","affiliation":[{"name":"National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Jalah","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , , 6720A Rockledge Drive , , ,","place":["Bethesda, Maryland, United States, 20817"]},{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua F. G.","family":"Antoline","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar B.","family":"Torres","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , , 6720A Rockledge Drive , , ,","place":["Bethesda, Maryland, United States, 20817"]},{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory H.","family":"Imler","sequence":"additional","affiliation":[{"name":"Naval Research Laboratory , , ,","place":["Washington, D.C., United States, 20375"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Deschamps","sequence":"additional","affiliation":[{"name":"Naval Research Laboratory , , ,","place":["Washington, D.C., United States, 20375"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Beck","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , , 6720A Rockledge Drive , , ,","place":["Bethesda, Maryland, United States, 20817"]},{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Alving","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2074-2373","authenticated-orcid":true,"given":"Gary R.","family":"Matyas","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"2026090314012135500_cit1","unstructured":"Results\nfrom the 2013 National Survey on Drug Use and Health: Summary of National\nFindings; NSDUH Series H-48, HHS Publication No.\n(SMA) 14-4863; Substance Abuse and Mental\nHealth Services Administration: Rockville,\nMD, 2014; pp 1\u2013169."},{"key":"2026090314012135500_cit2","unstructured":"Center for\nBehavioral Health Statistics and Quality.  Key Substance Use\nand Mental Health Indicators in the United States: Results from the\n2015 National Survey on Drug Use and Health; NSDUH\nSeries H-51, HHS Publication No. (SMA) 16-4984; Center for Behavioral Health Statistics and Quality, Substance Abuse\nand Mental Health Services Administration: Rockville, MD, 2016; pp 1\u201374."},{"key":"2026090314012135500_cit3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.15585\/mmwr.mm6552a12","article-title":"QuickStats: Rates of drug overdose deaths involving\nheroin, by selected age groups\u2500United States, 2006\u20132015","volume":"65","year":"2017","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"2026090314012135500_cit4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2005.06.010","article-title":"Medications development: successes and challenges","volume":"108","author":"Vocci","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"2026090314012135500_cit5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jsat.2014.06.006","article-title":"Buprenorphine\npharmacotherapy and behavioral treatment: comparison of outcomes among\nprescription opioid users, heroin users and combination users","volume":"48","author":"Nielsen","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"2026090314012135500_cit6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/adb.12163","article-title":"Abuse potential\nof intranasal buprenorphine\nversus buprenorphine\/naloxone in buprenorphine-maintained heroin users","volume":"20","author":"Jones","year":"2015","journal-title":"Addict Biol."},{"key":"2026090314012135500_cit7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"2026090314012135500_cit8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0031-6997(25)06605-0","article-title":"Antibodies to morphine,\nbarbiturates, and serotonin","volume":"25","author":"Spector","year":"1973","journal-title":"Pharmacol. Rev."},{"key":"2026090314012135500_cit9","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting\nSynthetic Designer Opioids: A conjugate\nvaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026090314012135500_cit10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nri3130","article-title":"Vaccines targeting drugs of abuse: is the glass half-empty\nor half-full?","volume":"12","author":"Janda","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"2026090314012135500_cit11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/j.2042-7158.1992.tb05474.x","article-title":"The effect of temperature and pH\non the deacetylation of diamorphine in aqueous solution and in human\nplasma","volume":"44","author":"Barrett","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"2026090314012135500_cit12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/187152711799219316","article-title":"Developing\na vaccine against multiple psychoactive targets: a case study of heroin","volume":"10","author":"Stowe","year":"2011","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"2026090314012135500_cit13","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin\nvaccine that prevents relapse to\nheroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"2026090314012135500_cit14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1021\/acs.bioconjchem.5b00085","article-title":"Efficacy, but not\nantibody titer or affinity, of a heroin hapten conjugate vaccine correlates\nwith increasing hapten densities on tetanus toxoid, but not on CRM197\ncarriers","volume":"26","author":"Jalah","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"2026090314012135500_cit15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A morphine\nconjugate vaccine attenuates\nthe behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"2026090314012135500_cit16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A morphine\/heroin\nvaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J. Neurochem."},{"key":"2026090314012135500_cit17","doi-asserted-by":"publisher","first-page":"pyu093","DOI":"10.1093\/ijnp\/pyu093","article-title":"A conjugate\nvaccine attenuates morphine- and heroin-induced behavior in rats","volume":"18","author":"Li","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"2026090314012135500_cit18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.vaccine.2014.01.028","article-title":"Facial recognition of heroin vaccine\nopiates: type 1 cross-reactivities of antibodies induced by hydrolytically\nstable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","volume":"32","author":"Matyas","year":"2014","journal-title":"Vaccine"},{"key":"2026090314012135500_cit19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective\neffects of a morphine conjugate vaccine on heroin and metabolite distribution\nand heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J. Pharmacol.\nExp. Ther."},{"key":"2026090314012135500_cit20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route\nand TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol. Pharmaceutics"},{"key":"2026090314012135500_cit21","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake\nof heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090314012135500_cit22","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine\nstrategy that induces protective\nimmunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026090314012135500_cit23","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable\nheroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"2026090314012135500_cit24","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.1039\/C4OB01053A","article-title":"Synthesis\nand immunological effects of heroin vaccines","volume":"12","author":"Li","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"2026090314012135500_cit25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41541-017-0013-9","article-title":"Heroin-HIV-1 (H2) vaccine: induction of dual immunologic\neffects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide\nwith liposomal lipid A as an adjuvant","volume":"2","author":"Torres","year":"2017","journal-title":"npj Vaccines"},{"key":"2026090314012135500_cit26","unstructured":"Drugs of Abuse, A DEA Resource Guide: 2017 ed.; Penny Hill Press, 2017; https:\/\/go.usa.gov\/xN7Qm."},{"key":"2026090314012135500_cit27","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1021\/jo00185a072","article-title":"A new reagent\nfor the selective, high-yield N-dealkylation of tertiary\namines: improved syntheses of naltrexone and nalbuphine","volume":"49","author":"Olofson","year":"1984","journal-title":"J. Org. Chem."},{"key":"2026090314012135500_cit28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1039\/c39780000315","article-title":"Conversion of alkyl carbamates into amines via treatment\nwith trimethylsilyl iodide","author":"Jung","year":"1978","journal-title":"J. Chem. Soc., Chem.\nCommun."},{"key":"2026090314012135500_cit29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1246\/cl.1983.927","article-title":"Palladium-catalyzed\naromatic amination\nof aryl bromides with N,N-dimethylamino-tributyltin","volume":"12","author":"Kosugi","year":"1983","journal-title":"Chem. Lett."},{"key":"2026090314012135500_cit30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1039\/C0SC00331J","article-title":"Dialkylbiaryl phosphines in Pd-catalyzed amination:\nA user\u2019s guide","volume":"2","author":"Surry","year":"2011","journal-title":"Chem. Sci."},{"key":"2026090314012135500_cit31","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1021\/cr8002505","article-title":"Copper-mediated coupling reactions\nand their applications in natural products and designed biomolecules\nsynthesis","volume":"108","author":"Evano","year":"2008","journal-title":"Chem. Rev."},{"key":"2026090314012135500_cit32","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1021\/ol401208t","article-title":"Synthesis and application\nof palladium precatalysts\nthat accommodate extremely bulky di-tert-butylphosphino biaryl ligands","volume":"15","author":"Bruno","year":"2013","journal-title":"Org. Lett."},{"key":"2026090314012135500_cit33","doi-asserted-by":"publisher","first-page":"16720","DOI":"10.1021\/ja9044357","article-title":"Pd-catalyzed N-arylation of secondary acyclic amides: catalyst development,\nscope, and computational study","volume":"131","author":"Hicks","year":"2009","journal-title":"J. Am. Chem.\nSoc."},{"key":"2026090314012135500_cit34","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1055\/s-0032-1316683","article-title":"An efficient\nmethod for reductive amination of carbonyl\ncompounds under nonacidic conditions","volume":"23","author":"Hudson","year":"2012","journal-title":"Synlett"},{"key":"2026090314012135500_cit35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.tet.2003.12.024","article-title":"Chemoselective reductive alkylation\nof ammonia with carbonyl compounds: synthesis of primary and symmetrical\nsecondary amines","volume":"60","author":"Miriyala","year":"2004","journal-title":"Tetrahedron"},{"key":"2026090314012135500_cit36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00397910902978007","article-title":"Additive-fee chemoselective\nacylation of amines","volume":"40","author":"Temperini","year":"2009","journal-title":"Synth. Commun."},{"key":"2026090314012135500_cit37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0957-4166(02)00336-1","article-title":"CAL-B-catalyzed resolution of some\npharmacologically interesting \u03b2-substituted isopropylamines","volume":"13","author":"Gonza\u0301lez-Sabi\u0301n","year":"2002","journal-title":"Tetrahedron: Asymmetry"},{"key":"2026090314012135500_cit38","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1016\/j.vaccine.2015.09.001","article-title":"Differential immune responses to\nHIV-1 envelope protein\ninduced by liposomal adjuvant formulations containing monophosphoryl\nlipid A with or without QS21","volume":"33","author":"Beck","year":"2015","journal-title":"Vaccine"},{"key":"2026090314012135500_cit39","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00216-015-9223-z","article-title":"A simple nonradioactive\nmethod for the determination of the binding affinities of antibodies\ninduced by hapten bioconjugates for drugs of abuse","volume":"408","author":"Torres","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"2026090314012135500_cit40","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1016\/j.vaccine.2014.07.085","article-title":"Adjuvants\nfor vaccines to drugs of abuse and addiction","volume":"32","author":"Alving","year":"2014","journal-title":"Vaccine"},{"key":"2026090314012135500_cit41","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","article-title":"Comparative effects of carrier proteins\non vaccine-induced immune response","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"2026090314012135500_cit42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/COH.0000000000000315","article-title":"Adjuvants for HIV\nvaccines","volume":"11","author":"Rao","year":"2016","journal-title":"Curr.\nOpin. HIV AIDS"},{"key":"2026090314012135500_cit43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1517\/17425247.2016.1151871","article-title":"Liposomal\nadjuvants\nfor human vaccines","volume":"13","author":"Alving","year":"2016","journal-title":"Expert Opin. Drug Delivery"},{"key":"2026090314012135500_cit44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1586\/erv.12.35","article-title":"Liposomes containing\nlipid A: an effective, safe, generic adjuvant system for synthetic\nvaccines","volume":"11","author":"Alving","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"2026090314012135500_cit45","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing\nmonophosphoryl lipid A: a potent\nadjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"key":"2026090314012135500_cit46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0076-6879(03)73003-1","article-title":"Oil-in-water liposomal\nemulsions\nfor vaccine delivery","volume":"373","author":"Matyas","year":"2003","journal-title":"Methods Enzymol."},{"key":"2026090314012135500_cit47","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1360-0443.2004.00744.x","article-title":"Comparison\nof acute lethal toxicity of commonly abused psychoactive substances","volume":"99","author":"Gable","year":"2004","journal-title":"Addiction"},{"key":"2026090314012135500_cit48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5483\/BMBRep.2013.46.1.001","article-title":"Transcutaneous\nantigen delivery system","volume":"46","author":"Lee","year":"2013","journal-title":"BMB Rep"},{"key":"2026090314012135500_cit49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased\nlocomotor activity induced by heroin in mice: pharmacokinetic demonstration\nof heroin acting as a prodrug for the mediator 6-monoacetylmorphine\nin vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026090314012135500_cit50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship\nbetween nonmedical prescription-opioid\nuse and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"2026090314012135500_cit51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin\ncrisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu. Rev. Public Health"},{"key":"2026090314012135500_cit52","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in\nchronic pain--misconceptions and mitigation\nstrategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"2026090314012135500_cit53","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and\noxycodone vaccines\nreduces the distribution of 6-monoacetylmorphine and oxycodone to\nbrain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"key":"2026090314012135500_cit54","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids\nin rats and mice by vaccination with immunogens containing oxycodone\nand hydrocodone haptens","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090314012135500_cit55","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1007\/s00216-014-8035-x","article-title":"Characterization and optimization\nof heroin hapten-BSA conjugates: method development for the synthesis\nof reproducible hapten-based vaccines","volume":"406","author":"Torres","year":"2014","journal-title":"Anal.\nBioanal. Chem."},{"key":"2026090314012135500_cit56","doi-asserted-by":"publisher","DOI":"10.1002\/0471142301.ns0809s41","article-title":"Models of nociception: hot-plate,\ntail-flick, and formalin tests in rodents","volume-title":"Current Protocols in Neuroscience","author":"Bannon","year":"2007"},{"key":"2026090314012135500_cit57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"2026090314012135500_cit58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FBP.0000000000000026","article-title":"Assessment of thermal sensitivity in rats using the\nthermal place preference test: description and application in the\nstudy of oxaliplatin-induced acute thermal hypersensitivity and inflammatory\npain models","volume":"25","author":"Balayssac","year":"2014","journal-title":"Behav. Pharmacol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.7b01427","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/61\/1\/329\/67315425\/acs.jmedchem.7b01427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/61\/1\/329\/67315425\/acs.jmedchem.7b01427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:50:16Z","timestamp":1788857416000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/61\/1\/329\/696464\/A-Stable-Heroin-Analogue-That-Can-Serve-as-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,13]]},"published-print":{"date-parts":[[2018,1,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01427","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]}}}